How the FDA Approved a $300,000-a-Year Drug Its Own Experts Didn't Believe Worked

After trial data for a new medicine proved inconclusive, Sarepta Therapeutics joined with the parents of sick boys to persuade officials it helped.

from WSJ.com: US Business http://ift.tt/2pX17m5
via IFTTT